Immunotherapy of acute myelogenous leukemia in man.
D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use*; D003429:Cross Reactions; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D007111:Immunity, Cellular; D007114:Immunization; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D009163:Mycobacterium bovis / Q000276:immunology*; D012075:Remission, Spontaneous
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D003561:Cytarabine; D003630:Daunorubicin